Photo highlights from ExL Pharma's September Conference: Merging eHR & EDC.
Participants from the pharmaceutical industry, HIT, EDC, NIH, and academia gathered in Washington, DC in September to explore, discuss, debate, and resolve present issues confronting and challenging the use of electronic health records (eHR) and electronic data capture (EDC) in clinical research.
Day One of ExL Pharma's "Merging eHR & EDC" Conference began with a hearty discussion of whether eHR and EDC can be merged. The discussion flowed well into Day Two's presentations on practical approaches to implementation and convergence.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Oveporexton Shows Superior Efficacy in Phase II Narcolepsy Type 1 Trial Without Hepatotoxicity
May 16th 2025In the TAK-861-2001 Phase IIb study, oveporexton significantly improved wakefulness, daytime sleepiness, and cataplexy frequency in patients with narcolepsy type 1, outperforming current therapies and avoiding liver toxicity seen with earlier OX2R agonists, according to results published in The New England Journal of Medicine.